Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 10-Q stays in one workspace.
ACXP
$1.33
+4.72%
ACXP
· Acurx Pharmaceuticals, Inc.
$1.33
+0.06 (+4.72%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 13, 2026
Market Cap
$7.09M
Shares
5.27M
Volume · Oct 5
109.46K
Avg daily vol (3M)
128.45K
All webcasts
Earnings call · FY2026 Q2
Acurx Pharmaceuticals, Inc. (ACXP) Q2 2026 Earnings Call
Research coverage
1 live source
Open each available source without leaving this research workspace.
Diluted EPS
-$0.53
Net income
-$2.25M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC periodic report
10-Q report
Filed Aug 13, 2026 · complete as-filed document